It sure does in a way; specifically when they tried to save their nasdaq listing while gaining a revenue generating diabetes mail order company. Now they’re trying to uplist- their main goal. Since Joe is always the man with the plan, I’d rather him as ceo with the power to push forward rather than a consultant. If the revenue projections are accurate, then that’s a huge plus as they also move into new states. The funding needs to come together though. Joe the ceo also gaurentees the Note etc, if I worded that correctly. I don’t really understand but it’s like putting risk and your name on the line. So, he must be confident of his plan coming to fruition. Always understand dilution occurs, but if the value is true that’s different.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links